Indivior Pharmaceuticals, Inc. (INDV)
32.70
+1.19
(+3.78%)
USD |
NASDAQ |
Apr 17, 16:00
32.71
+0.01
(+0.03%)
After-Hours: 20:00
Indivior Pharmaceuticals SG&A Expense (Quarterly) : 189.00M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 82.79M |
| Catalyst Pharmaceuticals, Inc. | 48.23M |
| Pulse Biosciences, Inc. | 7.33M |
| Revolution Medicines, Inc. | 66.68M |
| Theravance Biopharma, Inc. | 20.96M |